SAN DIEGO, CA / ACCESSWIRE / May 11, 2016 / Imprimis Pharmaceuticals, Inc. IMMY will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Thursday, May 12, 2016 at 4:30 PM Eastern Time.
To participate in this event, dial 877-407- 8035 domestically, or 201-689- 8035 internationally, approximately 5 to 10 minutes before the beginning of the call. Additionally, you can listen to the event online at www.investorcalendar.com/IC/CEPage.asp?ID=174995 or the Imprimis Pharmaceuticals website (www.imprimispharma.com).
If you are unable to participate during the live webcast, the event archive will be available at www.investorcalendar.com or www.imprimispharma.com.
You may access the teleconference replay by dialing 877-660-6853 domestically or 201-612-7415 internationally, referencing conference ID # 13636652. The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on June 12, 2016.
About Imprimis Pharmaceuticals
Imprimis Pharmaceuticals, Inc. (IMMY) is a national leader in the development, production and dispensing of novel compounded pharmaceuticals. The company's two business programs, Imprimis Cares™ and Custom Compounding Choice™, focus on patient outcomes and affordability by offering high quality customizable compounded drugs in all 50 states. Headquartered in San Diego, California, Imprimis owns and operates four dispensing facilities located in California, Texas, New Jersey and Pennsylvania. For more information about Imprimis, please visit the corporate website at www.ImprimisPharma.com.
SOURCE: Investor Calendar
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
